ArticleDiagnostics (Basel, Switzerland)2021

Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.

Federica Grosso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.